Services

Opportunity Assessment

Evaluate the market landscape and commercial potential of new products to drive strategic decisions

Key Steps

  • Crystallize client business questions
  • Conduct primary and secondary research
    • Primary research may include in-depth interviews, quantitative online surveys, and focus groups
    • Secondary research may include professional journals, conference proceedings and abstracts, pipeline and clinical trial databases, prescription data, and market and analyst reports
  • Generate and communicate product story in the context of market conditions and fit with client’s strategy

Typical Deliverables

  • Clinical and commercial market dynamics
  • Patient population (e.g., epidemiology, prevalence, segmentation)
  • Patient journey and role of key stakeholders
  • Pricing and reimbursement overview
  • Competitive environment implications
  • Reactions to target product profile
  • Clinical development considerations
  • Drivers of commercial success
  • Revenue and net present value (NPV) forecasting

View Case Study

Evaluation of the market potential for an asset being developed for a chronic respiratory indication

Asset/Portfolio Strategy

Prioritize individual assets based on market opportunities and a customized framework. This can entail prioritization among potential indications either for one asset or between different assets and different therapeutic categories

Key Steps

  • Crystallize client business questions
  • Understand the market landscape and how each asset could fit into the evolving clinical and commercial landscape
  • Develop a framework to compare options and optimize portfolio decision-making
  • Work with clients to ensure alignment

Typical Deliverables

  • Key success factors by indication or therapeutic area
  • Evaluation of how the clients’ product(s) may serve market needs
  • Distillation of a company’s vision for success for an asset or therapeutic area
  • Framework for evaluating future opportunities within the indication or therapeutic area
  • Areas for R&D or in-licensing to sustain the franchise

View Case Study

Assessment of potential lifecycle indications for a small molecule targeted therapy in biomarker-defined solid tumors

Asset Search and BD Analytics

Conduct search and evaluation analysis to identify and characterize relevant assets or companies that fit clients’ criteria. Assess the commercial value of assets for buy- or sell-side clients.

Key Steps

  • Conduct extensive database searches to identify and prioritize assets of interest based on client-defined inclusion/exclusion criteria
  • Prioritize assets and develop profiles outlining opportunities and risks of high-interest targets
  • Conduct in depth primary and secondary research on selected assets to further help refine potential opportunities of interest
  • Reach out to asset holders to assess asset actionability
  • Assess and analyze asset situation and key sensitivities in valuation and develop a financial forecast model — revenue or NPV

Typical Deliverables

  • Detailed databases created for unique asset opportunities and with client-defined criteria
  • Insights into asset positioning that can lead to recrafted slide presentations, teasers, and target product profiles that clients can use in external communication and pitches with investors and partners
  • Financial valuations (epidemiology- or prescription-based models), as well as comparable company, product, and transaction analyses
  • “NPV split” analysis to compare non-binding terms sheets to provide clients with insights into the retained vs. out-licensed value in a transaction

View Case Study One

Asset search for business development opportunities for a company seeking to expand its rare disease portfolio, focused on central nervous system diseases

View Case Study Two

Commercial diligence for the selling company in the context of an M&A transaction

Commercial Planning:
Competitive Strategy

Create up-to-date competitive landscape scenarios and facilitate cross-functional alignment on strategies and messaging

Key Steps

  • Build comprehensive competitive market situation analyses
  • Develop competitive scenarios
  • Run interactive workshops for cross-functional client teams
  • Develop and document responses stemming from client meetings and workshops

Typical Deliverables

  • Market situation analysis pre-read materials
  • Competitive scenarios and workshop plan
  • Workshop development and facilitation
  • Post-workshop summary of strategic recommendations and tactics

View Case Study

Simulation workshop to prepare for competitive strategy and messaging for a new AML drug

Commercial Planning:
Market Readiness Strategy

Develop early launch plans for successful commercialization of a new drug

Key Steps

  • Conduct market assessment to understand how asset can fulfill unmet needs
  • Develop patient journey to understand key hurdles for asset to clear
  • Benchmark key competitors to understand market approach
  • Help organization evaluate and operationalize strategies (e.g., “go alone” vs. “partner” vs. “license out”)
  • Run interactive workshops for cross-functional client teams

Typical Deliverables

  • Key success factors for asset to realize commercial potential
  • Framework of strategic initiatives leading up to launch
  • Pre-commercial budget and headcount build-out

View Case Study

Developing go-to-market strategy for a novel oncology agent for a rare biomarker selected indication

China Market Entry Strategy

Assist ex-China companies in developing China market landscape, opportunity sizing, partner list, and entry strategy

Key Steps

  • Review market data, pricing and reimbursement status, and government policies
  • Conduct in-depth interviews with key opinion leader clinicians and commercial experts in China
  • Develop key insights on market trends, product opportunities, and hurdles
  • Recommend China entry strategy, key initiatives, and potential partners

Typical Deliverables

  • Robust market landscape assessment, directly conducted by experienced Bluestar team in U.S. and China
  • Rich insights on the unique market dynamic in China and the requisite strategic approaches
  • Action-oriented recommendations that directly support client’s BD&L initiatives and pipeline strategy

View Case Study

Curation of partnering candidates and detailed revenue forecast to support licensing initiatives

Bluestar BioAdvisors, LLC

521 Fifth Avenue, 25th Floor
New York, NY USA 10175

(212) 257-6030

©2018–2024 Bluestar BioAdvisors, LLC. All rights reserved.